PCMA’s Merritt issues statement on drug pricing

Print Friendly, PDF & Email
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.

“News of recent price increases by drugmakers further confirms that the easiest way to lower costs would be for drug companies to lower their prices.”

This news follows an Office of Inspector General, Health and Human Services report that debunked the myth that drugmakers have somehow been compelled to raise prices because of the discounts and rebates health plans and PBMs demand to reduce overall costs.”



Comments are closed.